Clinical trial
Phase II Study of BAY 43-9006 in Japanese Patients With Renal Cell Carcinoma
NCT00661375 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of BAY 43-9006 in Japanese Patients With Renal Cell Carcinoma
- Lead sponsor
- Bayer
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- March 31, 2006
- Enrollment
- 131 (actual)
- Sites
- 51
Conditions
As the registry lists them; a condition with its own page is linked.